Latest Ally Bridge Group (NY) LLC Stock Portfolio
$167Million– No. of Holdings #25
Ally Bridge Group (NY) LLC Performance:
2024 Q2: 3.34%YTD: 16.48%2023: 23.22%
Performance for 2024 Q2 is 3.34%, and YTD is 16.48%, and 2023 is 23.22%.
About Ally Bridge Group (NY) LLC and 13F Hedge Fund Stock Holdings
Ally Bridge Group (NY) LLC is a hedge fund based in NEW YORK, NY. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $146.7 Millions. In it's latest 13F Holdings report, Ally Bridge Group (NY) LLC reported an equity portfolio of $167.9 Millions as of 30 Jun, 2024.
The top stock holdings of Ally Bridge Group (NY) LLC are SLNO, SRPT, GERN. The fund has invested 7% of it's portfolio in SOLENO THERAPEUTICS INC and 6.9% of portfolio in SAREPTA THERAPEUTICS INC.
The fund managers got completely rid off VERONA PHARMA PLC (VRNA), AVADEL PHARMACEUTICALS PLC (AVDL) and DIANTHUS THERAPEUTICS INC stocks. They significantly reduced their stock positions in BLUEPRINT MEDICINES CORP (BPMC), INSMED INC (INSM) and CG ONCOLOGY INC. Ally Bridge Group (NY) LLC opened new stock positions in SAREPTA THERAPEUTICS INC (SRPT), LEGEND BIOTECH CORP and DAY ONE BIOPHARMACEUTICALS I (DAWN). The fund showed a lot of confidence in some stocks as they added substantially to CONTEXT THERAPEUTICS INC (CNTX).
The top stock holdings of Ally Bridge Group (NY) LLC are SLNO, SRPT, GERN. The fund has invested 7% of it's portfolio in SOLENO THERAPEUTICS INC and 6.9% of portfolio in SAREPTA THERAPEUTICS INC.
The fund managers got completely rid off VERONA PHARMA PLC (VRNA), AVADEL PHARMACEUTICALS PLC (AVDL) and DIANTHUS THERAPEUTICS INC stocks. They significantly reduced their stock positions in BLUEPRINT MEDICINES CORP (BPMC), INSMED INC (INSM) and CG ONCOLOGY INC. Ally Bridge Group (NY) LLC opened new stock positions in SAREPTA THERAPEUTICS INC (SRPT), LEGEND BIOTECH CORP and DAY ONE BIOPHARMACEUTICALS I (DAWN). The fund showed a lot of confidence in some stocks as they added substantially to CONTEXT THERAPEUTICS INC (CNTX).
Ally Bridge Group (NY) LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2024
Ally Bridge Group (NY) LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Ally Bridge Group (NY) LLC made a return of 3.34% in the last quarter. In trailing 12 months, it's portfolio return was 44.01%.
New Buys
| Ticker | $ Bought |
|---|---|
| sarepta therapeutics inc | 11,613,000 |
| legend biotech corp | 8,636,550 |
| alumis inc | 8,229,380 |
| disc medicine inc | 7,504,160 |
| day one biopharmaceuticals i | 7,387,390 |
| avadel pharmaceuticals plc | 6,049,240 |
| trevi therapeutics inc | 4,395,280 |
| tyra biosciences inc | 4,231,910 |
New stocks bought by Ally Bridge Group (NY) LLC
Additions
| Ticker | % Inc. |
|---|---|
| context therapeutics inc | 159 |
Additions to existing portfolio by Ally Bridge Group (NY) LLC
Reductions
| Ticker | % Reduced |
|---|---|
| blueprint medicines corp | -53.01 |
| insmed inc | -48.4 |
| cg oncology inc | -45.42 |
| xenon pharmaceuticals inc | -45.25 |
| merus n v | -31.68 |
| jasper therapeutics inc | -24.6 |
| longboard pharmaceuticals in | -19.06 |
| kura oncology inc | -15.97 |
Ally Bridge Group (NY) LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| lyra therapeutics inc | -6,243,270 |
| mersana therapeutics inc | -3,590,440 |
| verona pharma plc | -11,854,100 |
| olema pharmaceuticals inc | -6,328,280 |
| avadel pharmaceuticals plc | -9,239,440 |
| rapt therapeutics inc | -3,771,600 |
| marinus pharmaceuticals inc | -3,568,750 |
| dianthus therapeutics inc | -6,509,040 |
Ally Bridge Group (NY) LLC got rid off the above stocks
Sector Distribution
Ally Bridge Group (NY) LLC has about 76.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 76.2 |
| Others | 23.8 |
Market Cap. Distribution
Ally Bridge Group (NY) LLC has about 12.1% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 31.4 |
| UNALLOCATED | 23.8 |
| MID-CAP | 21.9 |
| LARGE-CAP | 12.1 |
| MICRO-CAP | 9.9 |
Stocks belong to which Index?
About 33.7% of the stocks held by Ally Bridge Group (NY) LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 66.3 |
| RUSSELL 2000 | 33.7 |
Ally Bridge Group (NY) LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Ally Bridge Group (NY) LLC
Ally Bridge Group (NY) LLC has 25 stocks in it's portfolio. About 55.9% of the portfolio is in top 10 stocks. PRAX proved to be the most loss making stock for the portfolio. INSM was the most profitable stock for Ally Bridge Group (NY) LLC last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AVDL | avadel pharmaceuticals plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BDTX | black diamond therapeutics i | 2.32 | 835,000 | 3,891,100 | new | |||
| BPMC | blueprint medicines corp | 4.86 | 75,638 | 8,152,260 | reduced | -53.01 | ||
| CNTX | context therapeutics inc | 2.25 | 1,886,230 | 3,781,900 | added | 159 | ||
| DAWN | day one biopharmaceuticals i | 4.40 | 536,095 | 7,387,390 | new | |||
| ELYM | eliem therapeutics inc | 2.12 | 500,000 | 3,555,000 | new | |||
| GERN | geron corp | 6.91 | 2,736,660 | 11,603,500 | reduced | -0.86 | ||
| INSM | insmed inc | 5.15 | 129,000 | 8,643,000 | reduced | -48.4 | ||
| JSPR | jasper therapeutics inc | 2.96 | 218,614 | 4,962,540 | reduced | -24.6 | ||
| KURA | kura oncology inc | 3.76 | 306,762 | 6,316,230 | reduced | -15.97 | ||
| LBPH | longboard pharmaceuticals in | 3.53 | 218,981 | 5,919,060 | reduced | -19.06 | ||
| LYRA | lyra therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| MNMD | mind medicine mindmed inc | 4.15 | 965,426 | 6,960,720 | reduced | -3.6 | ||
| MRNS | marinus pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| MRSN | mersana therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| MRUS | merus n v | 6.16 | 174,844 | 10,345,500 | reduced | -31.68 | ||
| OLMA | olema pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| PMN | promis neurosciences inc | 0.95 | 1,059,580 | 1,589,370 | unchanged | 0.00 | ||
| PRAX | praxis precision medicines i | 3.78 | 153,379 | 6,343,760 | reduced | -3.83 | ||
| RAPT | rapt therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||